Punch & Associates Investment Management, Inc. Harvard Bioscience Inc Transaction History

Punch & Associates Investment Management, Inc.

$1.68 Billion
Q3 2024

A detailed history of Punch & Associates Investment Management, Inc. transactions in Harvard Bioscience Inc stock. As of the latest transaction made, Punch & Associates Investment Management, Inc. holds 2,772,700 shares of HBIO stock, worth $6.02 Million. This represents 0.44% of its overall portfolio holdings.

Number of Shares

2,772,700

Previous 2,772,339 0.01%

Holding current value

$6.02 Million

Previous $7.9 Million 5.61%

% of portfolio

0.44%

Previous 0.49%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$2.64 - $3.54 $953 - $1,277	361 Added 0.01%	2,772,700 $7.46 Million
Q1 2024 May 15, 2024	SELL	$4.02 - $5.39 $585,693 - $785,296	-145,695 Reduced 4.99%	2,772,339 $11.8 Million
Q4 2023 Feb 15, 2024	BUY	$4.0 - $5.49 $11.7 Million - $16 Million	2,918,034 New	2,918,034 $15.6 Million
Q3 2023 Oct 26, 2023	BUY	$4.0 - $5.82 $241,540 - $351,440	60,385 Added 2.11%	2,923,034 $12.6 Million
Q2 2023 Aug 14, 2023	SELL	$4.19 - $6.16 $354,809 - $521,628	-84,680 Reduced 2.87%	2,862,649 $15.7 Million
Q1 2023 May 15, 2023	BUY	$2.45 - $4.22 $449,060 - $773,483	183,290 Added 6.63%	2,947,329 $12.4 Million
Q4 2022 Feb 14, 2023	BUY	$2.12 - $2.86 $86,004 - $116,024	40,568 Added 1.49%	2,764,039 $7.66 Million
Q3 2022 Nov 14, 2022	BUY	$2.33 - $3.92 $161,291 - $271,358	69,224 Added 2.61%	2,723,471 $6.97 Million
Q2 2022 Aug 15, 2022	BUY	$3.28 - $6.42 $619,385 - $1.21 Million	188,837 Added 7.66%	2,654,247 $9.56 Million
Q1 2022 May 16, 2022	BUY	$5.16 - $7.14 $1.54 Million - $2.13 Million	298,635 Added 13.78%	2,465,410 $15.3 Million
Q4 2021 Feb 15, 2022	BUY	$6.37 - $8.18 $3.47 Million - $4.46 Million	545,000 Added 33.61%	2,166,775 $15.3 Million
Q3 2021 Nov 15, 2021	SELL	$6.98 - $8.47 $366,708 - $444,988	-52,537 Reduced 3.14%	1,621,775 $11.3 Million
Q2 2021 Aug 16, 2021	SELL	$5.44 - $8.4 $209,739 - $323,862	-38,555 Reduced 2.25%	1,674,312 $13.9 Million
Q1 2021 May 18, 2021	BUY	$3.91 - $6.99 $395,035 - $706,213	101,032 Added 6.27%	1,712,867 $9.35 Million
Q4 2020 Feb 16, 2021	BUY	$3.0 - $4.5 $222,105 - $333,157	74,035 Added 4.81%	1,611,835 $6.92 Million
Q3 2020 Nov 16, 2020	BUY	$2.75 - $4.2 $1.44 Million - $2.2 Million	523,000 Added 51.54%	1,537,800 $4.63 Million
Q2 2020 Aug 14, 2020	BUY	$2.12 - $3.14 $2.15 Million - $3.19 Million	1,014,800 New	1,014,800 $3.15 Million

Others Institutions Holding HBIO

# of Institutions

Shares Held

31.5M

Call Options Held

700

Put Options Held

2.1K

View Full List

About HARVARD BIOSCIENCE INC

Ticker HBIO
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 41,636,500
Market Cap $90.4M
Description
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...

More about HBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Punch & Associates Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Punch & Associates Investment Management, Inc. with notifications on news.

Account

Punch & Associates Investment Management, Inc. Harvard Bioscience Inc Transaction History